SCHEMBL3260435

SCHEMBL3260435

NC1CN(C=O)C(c2cc3ccccc3[nH]2)CN1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.37
HRH4 Q9H3N8 1/20 0.34
AOC3 Q16853 2/20 0.33
CA2 P00918 1/20 0.33
AKR1C3 P42330 2/20 0.32
VCP P55072 1/20 0.32
LOXL2 Q9Y4K0 1/20 0.31
FLT3 P36888 1/20 0.31
SMYD3 Q9H7B4 1/20 0.31
MAOB P27338 1/20 0.31
SLC6A3 Q01959 3/20 0.31
KDM4E B2RXH2 2/20 0.31
SLC6A4 P31645 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPK1 P28482 1/20 0.31
DAO P14920 2/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
SRD5A2 P31213 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4949929 0.74 CYP2A6 (0.41) CYP2A6HRH4AKR1C3MAOBSLC6A3
SCHEMBL12993141 0.66 CYP2A6 (0.44) CYP2A6HRH4AKR1C3FLT3MAOB
SCHEMBL2347852 0.65 CYP2A6 (0.37) CYP2A6HRH4AOC3CA2AKR1C3
SCHEMBL13162089 0.63 HRH3 (0.42) HRH4AOC3CA2AKR1C3VCP
SCHEMBL6985432 0.62 HRH3 (0.39) HRH4AKR1C3SLC6A3SLC6A4
SCHEMBL73543 0.61 AOC3 (0.47) CYP2A6AOC3CA2LOXL2FLT3
SCHEMBL6985477 0.61 DAO (0.46) CYP2A6AOC3CA2LOXL2FLT3
SCHEMBL4307334 0.61 CHRNA7 (0.39) HRH4AOC3SLC6A3SLC6A4BRD4
SCHEMBL13634946 0.61 CHRNB2 (0.50)
SCHEMBL6407259 0.60 HRH3 (0.40) HRH4SLC6A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7648979-B2 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives HOFFMANN-LA ROCHE INC. (US) 2010-01-19 US disclosed
US-7648979-B2 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives HOFFMANN-LA ROCHE INC. (US) 2010-01-19 US disclosed
EP-2118059-A1 5 -AMIDO- (IH- INDOL- 2 -YL) PIPERAZIN-1-YL-METHANONE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDS F. Hoffmann-Roche AG (CH) 2009-11-18 EP disclosed
WO-2008095823-A1 5 -AMIDO- (IH- INDOL- 2 -YL) PIPERAZIN-1-YL-METHANONE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-14 WO disclosed
US-20080188487-A1 5-AMIDO-(1H-INDOL-2-YL)-PIPERAZIN-1-YL-METHANONE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188487-A1 5-AMIDO-(1H-INDOL-2-YL)-PIPERAZIN-1-YL-METHANONE DERIVATIVES HRH4, HRH3, HRH2 CYP2A6 516/4885HRH4 1/4885AOC3 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.